Abstract
Of 177 gynecologic outpatients with cervical dysplasia studied, 29 (16%) were found to excrete Chlamydia trachomatis from their urogenital tract. Sera collected from 93 of these patients were significantly more often positive for and showed higher levels of antichlamydial micro-complement fixation (CF) and immunofluorescence (IF) antibodies than sera obtained from the controls. However, when the sera were tested for anti-herpesvirus type II (HSV-II) and cytomegalovirus (CMV) antibodies, no difference between the cases and the controls were encountered.
MeSH terms
-
Adolescent
-
Adult
-
Antibodies, Bacterial / analysis
-
Antibodies, Viral / analysis
-
Chlamydia Infections / complications
-
Chlamydia Infections / epidemiology*
-
Chlamydia Infections / immunology
-
Chlamydia trachomatis / immunology
-
Cytomegalovirus / immunology
-
Female
-
Genital Diseases, Female / complications
-
Genital Diseases, Female / epidemiology*
-
Genital Diseases, Female / immunology
-
Humans
-
Middle Aged
-
Prospective Studies
-
Simplexvirus / immunology
-
Uterine Cervical Dysplasia / complications*
-
Uterine Cervical Dysplasia / immunology
-
Uterine Cervical Neoplasms / complications*
Substances
-
Antibodies, Bacterial
-
Antibodies, Viral